Medical Writing Authors and Authorship Ghostwriting prevalence among AMWA and EMWA members (2005 to 2014)
emwa-spring-2016png

Volume 25, Issue 1 - Authors and Authorship

Ghostwriting prevalence among AMWA and EMWA members (2005 to 2014)

Abstract

Ghostwriting, defined as undisclosed substantial contributions by medical writers, is considered to be unethical by the American Medical Writers Association (AMWA), EMWA, and other professional associations.

Download the full article

References

  1. Rennie D, Flanagin A. Authorship! Authorship! Guests, ghosts, grafters, and the two-sided coin. JAMA. 1994;271(6):469-471.
  2. Sharp D. A ghostly crew. Lancet. 1998;351(9109):1076.
  3. Smith R. Beyond conflict of interest. Transparency is the key. BMJ. 1998;317(7154):291-292.
  4. Lanier WL. Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity? Mayo Clin Proc. 2009;84(9):771-775.
  5. Foote MA, Hamilton C, Royer MG. Contributions of medical writers to scientific publications. AMWA J. 2002;17(4):48.
  6. Jacobs A, Wager E. European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications. Curr Med Res Opin. 2005;21(2):317-321.
  7. Battisti WP, Wager E, Baltzer L, et al. Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3. Ann Intern Med. 2015:epub ahead of print.
  8. Huth EJ, Case K. The URM: twentyfive years old. Science Editor. 2004;27(1):17-21.
  9. International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: writing and editing for biomedical publication. 2006. Available from: http://www.icmje.org/recommendations/archives/2006_urm.pdf
  10. International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: writing and editing for biomedical publication. 2007. Available from: http://www.icmje.org/recommendations/archives/2007_urm.pdf
  11. International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: writing and editing for biomedical publication. 2008. Available from: http://www.icmje.org/recommendations/archives/2008_urm.pdf
  12. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. 2014. Available from: http://www.icmje.org/index.html
  13. Pharmaceutical Research and Manufacturers of America. Principles on conduct of clinical trials and communication of clinical trial results. 2014. Available from: http://phrma.org/sites/default/files/pdf/042009_clinical_trial_principles_final_0.pdf
  14. Royer MG, Hamilton CW. The story behind the AMWA Task Force on the Contribution of Medical Writers to Scientific Publications. AMWA J. 2002;17(3):5-6.
  15. Hamilton CW, Royer MG. AMWA Position Statement on the Contributions of Medical Writers to Scientific Pub lic - ations. AMWA J. 2003;18(1):13-15.
  16. Stretton S. Systematic review on the primary and secondary reporting of the prevalence of ghostwriting in the medical literature. BMJ Open. 2014;4(7):e004777.
  17. Hamilton CW, Jacobs A. Survey of AMWA and EMWA members who make substantial contributions to manuscripts (abstract 3). AMWA Journal. 2006;21(2):50.
  18. Jacobs A, Hamilton CW. Decreased evidence of ghostwriting in a 2008 vs 2005 survey of medical writers. Write Stuff. 2009;18(2):118-123.
  19. Hamilton CW, Jacobs A. Evidence of decreased ghostwriting in a series of three surveys of medical communicators conducted between 2005 and 2011 (abstract). AMWA J. 2011;27(3):115.
  20. Hamilton C, Peña T, Platt M, Gertel A. Transforming perceptions of medical writers from coal to diamonds – If Superman can do it, so can we! (open session 24). American Medical Writers Association Annual Conference. San Antonio, TX; 2015.
  21. Graf C, Battisti WP, Bridges D, et al. Research Methods & Reporting. Good publication practice for communicating company sponsored medical research: the GPP2 guidelines. BMJ. 2009;339:b4330.
  22. Hamilton CW, Hudson S, Gegeny T. AMWA Code of Ethics added to membership application and renewal forms. AMWA J. 2008;23(4):177-179.
  23. Marušić A, Hren D, Mansi B, et al. Five-step authorship framework to improve transparency in disclosing contributors to industry-sponsored clinical trial publications. BMC Med. 2014;12:197-206.
  24. Wager E, Woolley K, Adshead V, et al. Awareness and enforcement of guidelines for publishing industrysponsored medical research among publication professionals: the Global Publication Survey. BMJ Open. 2014;4(4):e004780.
  25. Woolley KL, Dickson T, Seth A, Stretton S. The Certified Medical Publication Professional (CMPP) credential: more than a knowledge test? (poster 30). 11th Annual Meeting of the International Society for Medical Publication Professionals. Arlington, VA; 2015.
  26. Woolley KL, Feeny S, Ralston J, Marchington J, Palmisano SM, McMurray B. For the greater good... Can agency competitors cooperate to advance medical publication practices? Med Writing. 2015;24(3):124-127.
  27. Woolley KL, Ely JA, Woolley MJ, et al. Declaration of medical writing assistance in international peerreviewed publications. JAMA. 2006;296(8):932-934.
  28. Flanagin A, Carey LA, Fontanarosa PB, et al. Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals. JAMA. 1998;280(3):222-224.
  29. Wislar JS, Flanagin A, Fontanarosa PB, DeAngelis CD. Honorary and ghost authorship in high impact biomedical journals: a cross sectional survey. BMJ. 2011;343:d6128. See also Web extra table 6125 and correction BMJ 2011;6343:d7677.

Search

Articles

Authors and Authorship
Letter from the Editor
President’s Message
Ghostwriting prevalence among AMWA and EMWA members (2005 to 2014)
The sun never sets on transparency
GPP3 – what is it, why is it necessary and what is new?
Attribution, advocacy, disposable authors, corporate ghosts and cultural assimilation: new themes in the ethical critique of commercial medical literature
Perspective from a leading scientific author: An interview with Professor Ruth Roberts on authors and authoring
Authorship of clinical trial documents
Project management in medical publication writing: A less explored avenue in pharmaceutical companies and clinical research organisations
Never say never! Returning to full-time employment after freelancing
Fifth EMWA freelance business survey
Journal Watch
In the Bookstores
The Webscout
Regulatory Writing: Authorship issues in regulatory documents
English Grammar and Style
Medical Communication
Lingua Franca and Beyond
Gained in Translation
Medical Writing Teaching
Profile: An interview with Phil Leventhal
EMWA’s 2016 Webinar Programme
Out on our own

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Feature Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief:

Co-Editor:

Managing Editor

  • Victoria White (Tampa, Florida, USA) Email: MEW@emwa.org
show all +

Associate Editors:

Section Editors:

Ad-hoc Editors:

  • Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)

Editor Emeritus: